DSD-T100

Androgen insensitivity syndrome · 47,XYY;45,X · DSD-T100

DSD-T100 · Persistent Müllerian duct syndrome · 2017 · Automated translation

Karyotype 47,XYY;45,X · Phenotypes HPO:0000028, HPO:0000047, Hypospadias (HP:0000047), Cryptorchidism (HP:0000028)

Partial androgen insensitivity syndrome with idiopathic intracranial hypertension, secondary abducens nerve palsy and subretinal fluid.

Case fields and evidence

Category

Androgen insensitivity syndrome

Sex

Female (living as female social gender).

Karyotype

47,XYY;45,X

Phenotypes

Hypospadias (HP:0000047); Cryptorchidism (HP:0000028)

Diagnosis

Partial androgen insensitivity syndrome with idiopathic intracranial hypertension, secondary abducens nerve palsy and subretinal fluid.

Follow-up

After 1 month, diplopia and abduction limitation had resolved; at 7 months, optic disc edema had decreased with improvement of subretinal fluid and visual fields; no change after discontinuing acetazolamide for 1 month; subsequently lost to follow-up.

General phenotype

Obese female phenotype; ophthalmologic examination showed best-corrected visual acuity 20/20 in both eyes, intraocular pressure 19 mmHg, pupils equal and round with normal light reflex, no relative afferent pupillary defect, and normal color vision.

Imaging

Pelvic MRI showed absent uterus and bilateral ovaries; brain MRI and venography were normal; fundus photography and OCT showed bilateral optic disc edema; visual field testing showed enlarged physiologic blind spot in both eyes; macular OCT showed subretinal fluid and disruption of the junctional band in the right eye.

Laboratory findings

Testosterone 3.6 ng/mL (normal for pubertal females 0.20–0.38 ng/mL); lumbar puncture opening pressure >50 cmH2O (normal 10–25), cerebrospinal fluid glucose 74 mg/dL, protein 16 mg/dL, no red or white blood cells.

Management

20% mannitol 400 mL intravenously and acetazolamide 500 mg orally for 7 days, then continued acetazolamide; estrogen was not discontinued.

Pathology

Not reported in the original text.

Evidence level

See source

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Limitations

See source

Cite this resource

DSD Research Library | Androgen insensitivity syndrome · 47,XYY;45,X · DSD-T100 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T100?version=v1.4.0